Doctors discover a new dementia that often gets misdiagnosed and 6.5 million people are at risk

Doctors are increasingly alarmed that a type of dementia which closely resembles Alzheimer's may have resulted in the ...

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial

First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation ...

Framework can improve Alzheimer's treatment efficacy by tracking anti-Aβ therapy response

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made ...

Alzheimer's drug hunt learns from cancer fight's multi-target playbook

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Analysis-Alzheimer's drug hunt learns from cancer fight's multi-target playbook

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
Raw Story

White House denies congresswoman's suggestion that Trump's taking Alzheimer drug

A Democratic lawmaker's "curious" theory about President Donald Trump's health forced an official White House denial.Rep.
The American Journal of Managed Care

Advancing Early Detection and Equitable Access in Alzheimer Disease Care

Experts at a roundtable in Boston, Massachusetts, on November 3, 2025, discussed improving early Alzheimer disease diagnosis, addressing workforce and equity gaps, and expanding access to new ...
Northern Virginia Daily

5 Advances in Alzheimer’s Care and Treatment in 2025

For the millions of Americans touched by Alzheimer’s disease, 2025 brought major advances in understanding of brain health ...